FDA Inspection 1001344 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on January 30, 2017 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)